ASH 2020 Highlights Podcast

Dr Rachel Giles guides us through 6 abstracts from the 62nd ASH Annual Meeting:

1. New therapy option emerges for chronic myeloid leukaemia patients - Luna et al -AND-
   STAMP inhibitor superior to bosutinib - Hochhaus et al


2. Venetoclax-hypomethylating agent combination therapy - Arslan et al


3. Largest gene therapy trial cohort to date in haemophilia B - Pipe et al


4. Myeloproliferative neoplasms can be driven by mutations - Williams et al


5. Cytoreductive chemotherapy in acute myeloid leukaemia - Kunhwa et al

© 2023 The Author(s). Published by Medicom Medical Publishers.
User license: Creative Commons Attribution – NonCommercial (CC BY-NC 4.0)

Posted on 9 December, 20202 February, 2021